⌘K

Login Start Free

Home/Filings/4/0001267602-19-000165

4//SEC Filing

Kaba Samer 4

Accession 0001267602-19-000165

CIK 0001267602other

View on SEC.gov Company Profile

Filed

Nov 3, 7:00 PM ET

Accepted

Nov 4, 8:58 AM ET

Size

4.6 KB

Accession

0001267602-19-000165

Insider Transaction Report

Form 4

Period: 2019-10-31

ALIMERA SCIENCES INCALIM

Chief Medical Officer

Transactions

Award
Common Stock
2019-10-31$0.28/sh+2,513$712→ 78,277 total

Footnotes (1)

[F1]These shares were acquired pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 4, 2019.

Documents

1 file

4
wf-form4_157287590700012.xmlPrimary
FORM 4

Issuer

ALIMERA SCIENCES INC

CIK 0001267602

Entity typeother

Related Parties

1

filerCIK 0001773634

Filing Metadata

Form type: 4
Filed: Nov 3, 7:00 PM ET
Accepted: Nov 4, 8:58 AM ET
Size: 4.6 KB

View on SEC.gov